Stride Post Latest News
Related Articles
According to the latest report by IMARC Group, titled, “Ablation Devices Market Trends: Global Industry, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global ablation devices market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 11% during 2021-2026.
Ablation devices refer to minimally invasive (MI) medical instruments utilized for the excision or removal of abnormal body tissues for therapeutic purposes. Their commonly used variants include fluid-cooled, temperature-controlled, robotic catheter manipulation and laser ablators, balloon ablation devices, tissue contact and spray probes, etc. These devices operate using various technologies, such as hydrothermal, laser, cryoablation, microwave, ultrasound, etc. They find extensive applications in treating different disorders, including oncological, ophthalmological, gynecological, urological, cardiovascular, etc., as well as in managing several chronic diseases, removing kidney stones and cancerous tumors, managing chronic neck, lower back, and arthritis pain, etc.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/ablation-devices-market/requestsample
Market Trends
The surging prevalence of life-threatening diseases, such as cancer, atrial fibrillation, chronic venous insufficiency (CVI), etc., is among the primary factors driving the ablation devices market. Moreover, the growing public awareness towards the increasing availability of effective ablation procedures is further augmenting the product demand. Additionally, the rising adoption of electrophysiology to remove abnormal tissues that cause irregular heart rhythms or cardiac arrhythmia is bolstering the market growth. Furthermore, the development of various innovative products, such as next-generation ablation devices with robotic navigation systems, is also catalyzing the global market. Besides this, the introduction of non-thermal, non-tumescent, and non-sclerosant endovenous variants for effectively treating superficial vein reflux is expected to stimulate the ablation devices market over the forecasted period.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Abbott Laboratories
- Angio Dynamics Inc.
- AtriCure Inc.
- Boston Scientific Corporation
- CONMED Corporation
- Elekta AB (publ)
- Johnson & Johnson
- Medtronic plc
- Olympus Corporation
- Smith & Nephew plc.
The report has segmented the market based on device technology, application and end user.
Breakup by Device Technology:
- Radiofrequency Devices
- Laser/Light Ablation
- Ultrasound Devices
- Cryoablation Devices
- Others
Breakup by Application:
- Cancer Treatment
- Cardiovascular Disease Treatment
- Ophthalmologic Treatment
- Gynecological Treatment
- Urological Treatment
- Cosmetic Surgery
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Table of Content:
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Ablation Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Device Technology
6.1 Radiofrequency Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Laser/Light Ablation
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Ultrasound Devices
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cryoablation Devices
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Application
7.1 Cancer Treatment
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular Disease Treatment
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Ophthalmologic Treatment
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Gynecological Treatment
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Urological Treatment
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Cosmetic Surgery
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AngioDynamics Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 AtriCure Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Boston Scientific Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 CONMED Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Elekta AB (publ)
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Johnson & Johnson
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medtronic plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Olympus Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Smith & Nephew plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Website: https://www.imarcgroup.com
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800
